Stem Cell Research and Profit Margins
While embryonic stem cell research potential grabs the headlines, adult stem cell treatment results are largely unknown. Why? Chuck Colson addresses the unsurprising answer in his article:
‘Lines that Divide’: Stem Cells and Profit Margins. It’s worth the read!
No responses yet